Sharmila Makhija named chair of the Department of Obstetrics & Gynecology and Women’s Health at Albert Einstein College of Medicine

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

SHARMILA MAKHIJA was named professor and chair of the Department of Obstetrics & Gynecology and Women’s Health at Albert Einstein College of Medicine and Montefiore Health System, effective April 1.

Previously, Makhija served as chair and professor of obstetrics and gynecology at University of Louisville School Of Medicine.

Makhija has also held faculty positions at the University of Pittsburgh School of Medicine/Magee-Women’s Hospital, the University of Alabama at Birmingham School of Medicine, and Emory University School of Medicine.

She is a fellow of the American College of Obstetrics and Gynecology and a member of the American Medical Association, American Association of Cancer Research, and the American Society of Gynecologic Cancer. She is on the editorial board of the Journal of Oncology Practice and has served on the editorial boards of Women’s Oncology Review Journal and the International Journal of Gynecological Cancer.

YOU MAY BE INTERESTED IN

Just consider for a minute if this was the first year of running your lab, if you were on the job market as a physician or scientist right now, if you were a resident contemplating a career in cancer research after fellowship, if you were a graduate student or postdoc, if you were an undergraduate or a technician who was looking toward graduate school.
The immune system can be a powerful tool to control cancer. Immune cells within our body detect cancer cells and release payloads that kill them. Transformative science in the last decade has led to the development of therapies that enhance the ability of our immune cells to carry out this function. These therapies, including checkpoint blockade and CAR-T cells, have been lifesaving for many patients that before had untreatable cancer. But, sadly, a majority of patients with advanced solid tumors still succumb to their disease. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login